Conto economico
BIOMARIN PHARMACEUTICAL INC
BMRN
Riepilogo performance
Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY | Dec 31, 2010 2010 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ricavi
|
3,221.25 | 2,853.92 | 2,419.23 | 2,096.04 | 1,846.28 | 1,860.46 | 1,704.05 | 1,491.21 | 1,313.65 | 1,116.85 | 889.90 | 751.04 | 548.49 | 500.72 | 441.36 | 376.27 |
|
Costo del venduto
|
717.44 | 580.24 | 514.85 | 483.67 | 470.52 | 524.27 | 359.47 | 315.26 | 241.79 | 209.62 | 152.01 | 129.76 | 95.74 | 91.83 | 84.02 | 70.29 |
|
Utile lordo
|
2,503.81 | 2,273.68 | 1,904.37 | 1,612.37 | 1,375.76 | 1,336.18 | 1,344.58 | 1,175.95 | 1,071.86 | 907.23 | 737.89 | 621.28 | 452.74 | 408.89 | 357.34 | 305.98 |
|
Spese operative
|
2,074.95 | 1,756.21 | 1,684.06 | 1,503.62 | 1,388.17 | 1,365.79 | 1,395.93 | 1,300.68 | 1,165.09 | 1,138.50 | 1,037.08 | 763.70 | 590.14 | 500.39 | 389.80 | 299.03 |
|
Ricerca e sviluppo
|
921.93 | 747.18 | 746.77 | 649.61 | 628.79 | 628.12 | 715.01 | 696.33 | 610.75 | 661.91 | 634.81 | 461.54 | 354.78 | 302.22 | 214.37 | 147.31 |
|
Spese commerciali, generali e amministrative
|
1,153.02 | 1,009.03 | 937.29 | 854.01 | 759.38 | 737.67 | 680.92 | 604.35 | 554.34 | 476.59 | 402.27 | 302.16 | 235.36 | 198.17 | 175.42 | 151.72 |
|
Altre spese operative
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Reddito operativo
|
428.86 | 517.47 | 220.31 | 108.76 | -12.41 | -29.60 | -51.35 | -124.73 | -93.23 | -231.26 | -299.19 | -142.42 | -137.39 | -91.50 | -32.46 | 6.95 |
|
Proventi/oneri non operativi
|
-53.62 | -24.29 | 31.75 | -40.82 | 62.94 | 12.72 | 43.46 | 17.97 | -57.35 | 599.79 | -144.47 | -17.56 | 39.11 | 26.78 | 11.17 | 28.44 |
|
Proventi da interessi
|
74.90 | 74.88 | 58.34 | 18.03 | 10.48 | 16.61 | 22.75 | 22.83 | 14.85 | 7.49 | 4.50 | 5.94 | 3.08 | 2.58 | 2.93 | 4.11 |
|
Oneri finanziari
|
9.55 | 12.73 | 17.34 | 15.97 | 15.34 | 29.31 | 23.46 | 43.66 | 42.71 | 39.50 | 38.24 | 36.64 | 10.45 | 7.64 | 8.35 | 10.33 |
|
Altri proventi/oneri non operativi
|
- | - | - | - | - | -0.01 | -0.59 | -0.55 | -1.29 | -0.54 | -0.82 | -0.88 | -1.15 | -1.22 | -2.43 | -2.99 |
|
Risultato prima delle imposte
|
482.48 | 541.76 | 188.56 | 149.58 | -75.35 | -42.32 | -94.81 | -142.71 | -35.88 | -0.12 | -154.72 | -124.87 | -176.50 | -118.28 | -43.63 | -21.49 |
|
Imposte sul reddito
|
133.58 | 114.90 | 20.92 | 8.02 | -11.27 | -901.42 | -70.96 | -65.49 | 81.17 | -200.84 | 17.08 | 9.10 | -0.15 | -3.93 | 10.21 | -21.49 |
|
Utile di pertinenza di terzi
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Utile netto
|
348.90 | 426.86 | 167.65 | 141.56 | -64.08 | 859.10 | -23.85 | -77.21 | -117.04 | -630.21 | -171.80 | -133.97 | -176.35 | -114.35 | -53.84 | 0.00 |
Informazioni supplementari
Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY | Dec 31, 2010 2010 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ammortamenti e svalutazioni
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
508.42 | 613.90 | 324.69 | 210.72 | 95.63 | 75.57 | 53.95 | -29.06 | -5.37 | -134.35 | -252.00 | -85.68 | -90.13 | -46.20 | 3.63 | 34.69 |
|
Utile per azione (base)
|
1.82 | 2.25 | 0.89 | 0.76 | -0.35 | 4.75 | -0.13 | -0.44 | -0.67 | -3.80 | - | - | - | -0.95 | -0.48 | 2.00 |
|
Utile per azione diluito
|
1.80 | 2.21 | 0.87 | 0.75 | -0.35 | 4.53 | -0.13 | -0.44 | -0.67 | -3.81 | - | - | - | -0.95 | -0.48 | 1.73 |
|
Media ponderata azioni
|
191.79 | 190.03 | 187.83 | 185.27 | 182.85 | 180.80 | 179.04 | 177.06 | 174.43 | 165.99 | - | - | - | 120.27 | 112.12 | 103.09 |
|
Media ponderata diluita azioni
|
197.39 | 196.71 | 191.60 | 188.96 | 182.85 | 191.68 | 179.04 | 177.27 | 174.43 | 166.22 | - | - | - | 120.27 | 112.12 | 125.67 |
|
Conto economico complessivo
|
273.78 | 517.30 | 142.72 | 123.26 | -33.51 | 822.80 | -8.96 | -48.39 | -152.82 | -638.43 | -178.23 | -111.52 | -171.13 | -119.44 | -49.14 | 205.07 |